Wave Life Sciences (WVE) Stock
Wave Life Sciences (WVE) closed at $3.13 on Nov 13, 2026; its Tenet Score is 54 of 100 against 407 Healthcare peers.
Key stats
- Previous close
- $3.13
- Nov 13, 2026
- Market cap
- $617.3M
- share price × the latest quarter's diluted weighted-average share count (vendor)
- Dividend yield
- 0.00%
- reinvests all
- 52-week range
- 3.00 – 21.73
- low → high
- Tenet Score
- 54/100
- Mixed · 407 Healthcare peers
Industry: Drugs · see every company filed here →
Wave Life Sciences Inc. scores 54/100. Mixed. Strongest on value and financial health, quality is the soft spot versus 407 Healthcare peers.
Tenet Score · vs sector
n=407Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Quality Compounder
- ✕ Drawdown Context
- ✕ Reversal Evidence
Pays no dividend. Every dollar of profit is reinvested into the business.
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to redu…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 13, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Universe Pharmaceuticals INCUPC | 64 | $688.4M |
| Cullinan Therapeutics IncCGEM | 54 | $667.4M |
| Olema Oncology Inc.OLMA | 55 | $662.3M |
| Immix Biopharma IncIMMX | 69 | $657.1M |
| Arbutus Biopharma CorpABUS | 49 | $627.0M |
| Geron Corp.GERN | 56 | $623.0M |
| Climb Bio Inc.CLYM | 62 | $608.5M |
| Sana Biotechnology IncSANA | 34 | $605.3M |
| Evotec SEEVO | 51 | $561.8M |
| Capricor Therapeutics IncCAPR | 51 | $554.1M |
Common questions
What sector and industry is Wave Life Sciences in?
Wave Life Sciences is in the Healthcare sector and the Drugs industry.
What is Wave Life Sciences' Tenet Score?
Wave Life Sciences' Tenet Score is 54 out of 100, ranked against 407 Healthcare peers as of Nov 15, 2026.




